Answers are grounded in this paper and cite their sources.
Sulbactam/durlobactam had excellent in vitro potency against A. baumannii isolates, including those that were resistant to imipenem/meropenem, amikacin, minocycline and colistin, compared with other compounds. Sulbactam/durlobactam has the potential to become a useful addition to the limited armamentarium of drugs that can be used to treat this problem pathogen.
No takes yet. Share an insight, caveat, or question.
Seifert et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: